CoChat

mdx Mice Manifest More Severe Muscle Dysfunction and Diaphragm Force Deficits than Do mdx Mice

Beastrom, Nicholas, Lu, Haiyan, Macke, Allison, Canan, Benjamin D., Johnson, Eric K., Penton, Christopher M., Kaspar, Brian K., Rodino-Klapac, Louise R., Zhou, Lan, Janssen, Paul M.L., Montanaro, Federica · 2011 · The American Journal of Pathology
Cited by 69

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ajpath.2011.07.009

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 63

  1. Monaco, 1986, Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene, Nature, 323, 646, 10.1038/323646a0 · DOI · Paper page
  2. Matsumura, 1993, The role of the dystrophin-glycoprotein complex in the molecular pathogenesis of muscular dystrophies, Neuromuscul Disord, 3, 533, 10.1016/0960-8966(93)90110-6 · DOI
  3. Zhou, 2010, Targeting fibrosis in Duchenne muscular dystrophy, J Neuropathol Exp Neurol, 69, 771, 10.1097/NEN.0b013e3181e9a34b · DOI · Paper page
  4. Mitrpant, 2009, Personalised genetic intervention for Duchenne muscular dystrophy: antisense oligomers and exon skipping, Curr Mol Pharmacol, 2, 110, 10.2174/1874467210902010110 · DOI
  5. Nelson, 2009, Emerging genetic therapies to treat Duchenne muscular dystrophy, Current Opin Neurol, 22, 532, 10.1097/WCO.0b013e32832fd487 · DOI
  6. Muir, 2009, Emerging strategies for cell and gene therapy of the muscular dystrophies, Expert Rev Mol Med, 11, e18, 10.1017/S1462399409001100 · DOI · Paper page
  7. Peault, 2007, Stem and progenitor cells in skeletal muscle development, maintenance, and therapy, Mol Ther, 15, 867, 10.1038/mt.sj.6300145 · DOI · Paper page
  8. Cossu, 2007, New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials, Trends Mol Med, 13, 520, 10.1016/j.molmed.2007.10.003 · DOI · Paper page
  9. McGeachie, 1993, Age-related changes in replication of myogenic cells in mdx mice: quantitative autoradiographic studies, J Neurol Sci, 119, 169, 10.1016/0022-510X(93)90130-Q · DOI · Paper page
  10. Pastoret, 1995, mdx mice show progressive weakness and muscle deterioration with age, J Neurol Sci, 129, 97, 10.1016/0022-510X(94)00276-T · DOI · Paper page
  11. Lefaucheur, 1995, Phenotype of dystrophinopathy in old mdx mice, Anat Rec, 242, 70, 10.1002/ar.1092420109 · DOI · Paper page
  12. Stedman, 1991, The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy, Nature, 352, 536, 10.1038/352536a0 · DOI · Paper page
  13. Chamberlain, 2007, Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma, FASEB J, 21, 10.1096/fj.06-7353com · DOI · Paper page
  14. Carnwath, 1987, Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles, J Neurol Sci, 80, 39, 10.1016/0022-510X(87)90219-X · DOI · Paper page
  15. Tanabe, 1986, Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse, Acta Neuropathol (Berl), 69, 91, 10.1007/BF00687043 · DOI · Paper page
  16. Torres, 1987, The mutant mdx: inherited myopathy in the mouse, Brain, 110, 269, 10.1093/brain/110.2.269 · DOI · Paper page
  17. Dangain, 1984, Muscle development in mdx mutant mice, Muscle Nerve, 7, 700, 10.1002/mus.880070903 · DOI · Paper page
  18. Muntoni, 1993, Muscular weakness in the mdx mouse, J Neurol Sci, 120, 71, 10.1016/0022-510X(93)90027-V · DOI
  19. Grounds, 2008, Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy, Neurobiol Dis, 31, 1, 10.1016/j.nbd.2008.03.008 · DOI · Paper page
  20. Spurney, 2009, Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures, Muscle Nerve, 39, 591, 10.1002/mus.21211 · DOI · Paper page
  21. Chapman, 1989, Recovery of Induced Mutations for X Chromosome-Linked Muscular Dystrophy in Mice, Proc Natl Acad Sci U S A, 86, 1292, 10.1073/pnas.86.4.1292 · DOI · Paper page
  22. Araki, 1997, Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy, Biochem Biophys Res Commun, 238, 492, 10.1006/bbrc.1997.7328 · DOI · Paper page
  23. Fukada, 2010, Genetic background affects properties of satellite cells and mdx phenotypes, Am J Pathol, 176, 2414, 10.2353/ajpath.2010.090887 · DOI · Paper page
  24. Im, 1996, Differential expression of dystrophin isoforms in strains of mdx mice with different mutations, Hum Mol Genet, 5, 1149, 10.1093/hmg/5.8.1149 · DOI · Paper page
  25. Danko, 1992, The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy, Pediatr Res, 32, 128, 10.1203/00006450-199207000-00025 · DOI · Paper page
  26. Haslett, 2005, The influence of muscle type and dystrophin deficiency on murine expression profiles, Mamm Genome, 16, 739, 10.1007/s00335-005-0053-8 · DOI
  27. Payne, 2006, Nutritional therapy improves function and complements corticosteroid intervention in mdx mice, Muscle Nerve, 33, 66, 10.1002/mus.20436 · DOI · Paper page
  28. Kobayashi, 2008, Sarcolemma-localized nNOS is required to maintain activity after mild exercise, Nature, 456, 511, 10.1038/nature07414 · DOI · Paper page
  29. Carter, 1999, Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation, J Neurosci, 19, 3248, 10.1523/JNEUROSCI.19-08-03248.1999 · DOI · Paper page
  30. Hamer, 2002, Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability, J Anat, 200, 69, 10.1046/j.0021-8782.2001.00008.x · DOI · Paper page
  31. Heydemann, 2009, Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice, J Clin Invest, 119, 3703, 10.1172/JCI39845 · DOI · Paper page
  32. Zhou, 2008, Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice, J Neurol Sci, 264, 106, 10.1016/j.jns.2007.08.029 · DOI
  33. Huang, 2009, Imatinib attenuates skeletal muscle dystrophy in mdx mice, FASEB J, 23, 2539, 10.1096/fj.09-129833 · DOI · Paper page
  34. Reddy, 1996, A simplified method for the analysis of hydroxyproline in biological tissues, Clin Biochem, 29, 225, 10.1016/0009-9120(96)00003-6 · DOI · Paper page
  35. Acharyya, 2007, Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy, J Clin Invest, 117, 889, 10.1172/JCI30556 · DOI · Paper page
  36. Chandrasekharan, 2010, A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy, Sci Transl Med, 2, 10.1126/scitranslmed.3000692 · DOI · Paper page
  37. Peterson, 2011, Peptide-based inhibition of NF-kappaB rescues diaphragm muscle contractile dysfunction in a murine model of Duchenne muscular dystrophy, Mol Med, 17, 508, 10.2119/molmed.2010.00263 · DOI
  38. Rucker, 2004, Rescue of enzyme deficiency in embryonic diaphragm in a mouse model of metabolic myopathy: pompe disease, Development, 131, 3007, 10.1242/dev.01169 · DOI
  39. Diaz, 1994, Effects of N-acetylcysteine on in vitro diaphragm function are temperature dependent, J Appl Physiol, 77, 2434, 10.1152/jappl.1994.77.5.2434 · DOI · Paper page
  40. Prezant, 1990, Temperature dependence of rat diaphragm muscle contractility and fatigue, J Appl Physiol, 69, 1740, 10.1152/jappl.1990.69.5.1740 · doi:10.1152/jappl.1990.69.5.1740
  41. Rodino-Klapac, 2007, A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy, J Transl Med, 5, 45, 10.1186/1479-5876-5-45 · DOI · Paper page
  42. Martin, 2009, Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild type mice, Am J Physiol Cell Physiol, 296, C476, 10.1152/ajpcell.00456.2008 · DOI · Paper page
  43. Rabinowitz, 2002, Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity, J Virol, 76, 791, 10.1128/JVI.76.2.791-801.2002 · DOI · Paper page
  44. Hauser, 1997, Improved adenoviral vectors for gene therapy of Duchenne muscular dystrophy, Neuromuscul Disord, 7, 277, 10.1016/S0960-8966(97)00052-7 · DOI
  45. Cohn, 2007, Myostatin does not regulate cardiac hypertrophy or fibrosis, Neuromuscul Disord, 17, 290, 10.1016/j.nmd.2007.01.011 · DOI
  46. Hayes, 1998, Contractile function and low-intensity exercise effects of old dystrophic (mdx) mice, Am J Physiol, 274, C1138, 10.1152/ajpcell.1998.274.4.C1138 · DOI
  47. Hooper, 1978, Bone length and muscle weight in mice subjected to genetic selection for the relative length of the tibia and radius, Life Sci, 22, 283, 10.1016/0024-3205(78)90529-5 · doi:10.1016/0024-3205(78)90529-5
  48. Golumbek, 2007, Strength and corticosteroid responsiveness of mdx mice is unchanged by RAG2 gene knockout, Neuromuscul Disord, 17, 376, 10.1016/j.nmd.2007.02.005 · doi:10.1016/j.nmd.2007.02.005
  49. Wang, 2009, Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice, J Orthop Res, 27, 421, 10.1002/jor.20781 · DOI · Paper page
  50. Zeman, 2000, Clenbuterol reduces degeneration of exercised or aged dystrophic (mdx) muscle, Muscle Nerve, 23, 521, 10.1002/(SICI)1097-4598(200004)23:4<521::AID-MUS10>3.0.CO;2-8 · DOI
  51. Wooddell, 2010, Use of Evans blue dye to compare limb muscles in exercised young and old mdx mice, Muscle Nerve, 41, 487, 10.1002/mus.21527 · DOI
  52. Yoshimura, 2004, AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype, Mol Ther, 10, 821, 10.1016/j.ymthe.2004.07.025 · DOI · Paper page
  53. Rodino-Klapac, 2010, Persistent expression of FLAG-tagged micro dystrophin in nonhuman primates following intramuscular and vascular delivery, Mol Ther, 18, 109, 10.1038/mt.2009.254 · DOI · Paper page
  54. Harper, 2002, Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy, Nat Med, 8, 253, 10.1038/nm0302-253 · DOI · Paper page
  55. Wang, 2005, Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart, Nature Biotechnol, 23, 321, 10.1038/nbt1073 · DOI · Paper page
  56. Lai, 2009, Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy, J Clin Invest, 119, 624, 10.1172/JCI36612 · DOI · Paper page
  57. McClive, 1994, C57BL/6 and C57BL/10 inbred mouse strains differ at multiple loci on chromosome 4, Immunogenetics, 39, 286, 10.1007/BF00188793 · doi:10.1007/bf00188793
  58. Slingsby, 1996, New microsatellite polymorphisms identified between C57BL/6, Immunogenetics, 43, 72
  59. Deacon, 2007, A comparison of the behavior of C57BL/6 and C57BL/10 mice, Behav Brain Res, 179, 239, 10.1016/j.bbr.2007.02.009 · DOI
  60. Lewis, 2005, Inbred mouse strain survey of sucrose intake, Physiol Behav, 85, 546, 10.1016/j.physbeh.2005.06.003 · DOI
  61. Rafael, 2000, Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice, Mamm Genome, 11, 725, 10.1007/s003350010149 · DOI
  62. Barton, 2006, Impact of sarcoglycan complex on mechanical signal transduction in murine skeletal muscle, Am J Physiol Cell Physiol, 290, C411, 10.1152/ajpcell.00192.2005 · DOI · Paper page
  63. Pegoraro, 2011, SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy, Neurology, 76, 219, 10.1212/WNL.0b013e318207afeb · DOI · Paper page

Cited by

See all 69

Metadata

Authors
Beastrom, N., Lu, H., Macke, A., Canan, B. D., Johnson, E. K., Penton, C. M., Kaspar, B. K., Rodino-Klapac, L. R., Zhou, L., Janssen, P. M. L., & Montanaro, F.
Venue
The American Journal of Pathology
Publisher
Elsevier BV
Published
2011-11
Volume
179
Issue
5
Pages
2464-2474
ISSN
0002-9440
Cited by
69
References
5
Language
en
Licence
Funders
  • National Institutes of Health (K02 HL083957)
  • American Heart Association
  • Research Institute, Nationwide Children's Hospital

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: mdx Mice Manifest More Severe Muscle Dysfunction and Diaphragm Force Deficits than Do mdx Mice. https://app.cochat.ai/papers/10.1016/j.ajpath.2011.07.009
The paper
Beastrom, N., Lu, H., Macke, A., Canan, B. D., Johnson, E. K., Penton, C. M., Kaspar, B. K., Rodino-Klapac, L. R., Zhou, L., Janssen, P. M. L., & Montanaro, F. (2011). mdx Mice Manifest More Severe Muscle Dysfunction and Diaphragm Force Deficits than Do mdx Mice. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2011.07.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.